Benzinga · Aug 5, 2026
BMO Capital Maintains Outperform on Andersons, Raises Price Target to $90
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
NYSE · ANDE
Consumer Defensive · Food Distribution
$68.06
Up+$0.74 (+1.10%)
Updated Aug 22, 2026, 1:03 PM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
ANDE closed at $68.06 after 21 trading sessions, down 12.42% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $68.18 | $69.3399 | $66.60 | $68.06 | 331.26K |
| Aug 20, 2026 | $67.49 | $69.16 | $66.87 | $67.32 | 306.52K |
| Aug 19, 2026 | $69.34 | $69.77 | $67.30 | $67.73 | 262.99K |
| Aug 18, 2026 | $69.32 | $71.2039 | $68.06 | $68.86 | 344.29K |
| Aug 17, 2026 | $65.73 | $69.02 | $65.73 | $68.88 | 359K |
| Aug 14, 2026 | $65.28 | $66.555 | $64.78 | $65.90 | 258.05K |
| Aug 13, 2026 | $65.91 | $66.09 | $64.66 | $65.14 | 271.96K |
| Aug 12, 2026 | $64.58 | $66.055 | $63.80 | $65.61 | 281.17K |
| Aug 11, 2026 | $65.49 | $66.018 | $63.815 | $64.10 | 337.21K |
| Aug 10, 2026 | $65.09 | $66.445 | $65.09 | $65.49 | 445.75K |
| Aug 7, 2026 | $67.73 | $67.75 | $65.075 | $65.39 | 515.8K |
| Aug 6, 2026 | $70.31 | $70.9999 | $67.74 | $67.95 | 321.62K |
| Aug 5, 2026 | $74.94 | $75.64 | $69.49 | $69.75 | 448.45K |
| Aug 4, 2026 | $76.81 | $77.35 | $72.69 | $74.48 | 583.89K |
| Aug 3, 2026 | $69.55 | $71.00 | $68.8896 | $69.86 | 357.86K |
| Jul 31, 2026 | $72.06 | $72.26 | $70.42 | $70.78 | 177.35K |
| Jul 30, 2026 | $70.47 | $72.795 | $69.48 | $71.52 | 398.41K |
| Jul 29, 2026 | $73.92 | $73.97 | $70.00 | $70.17 | 317.94K |
| Jul 28, 2026 | $75.19 | $76.6878 | $72.55 | $73.19 | 235.38K |
| Jul 27, 2026 | $77.26 | $77.805 | $73.42 | $74.60 | 298.86K |
| Jul 24, 2026 | $77.88 | $79.3999 | $76.20 | $77.71 | 224.61K |
The latest Smart Investors Daily articles mentioning ANDE.
ANDE research
Company profile and research snapshot.
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | BMO Capital | Outperform | — |
| May 7, 2026 | Benchmark | Buy | — |
| Feb 19, 2026 | BMO Capital | Outperform | — |
| Feb 5, 2026 | Benchmark | Buy | — |
| Dec 10, 2025 | BMO Capital | Outperform | — |
No generated briefing is available yet.
Benzinga · Aug 5, 2026
BMO Capital analyst Benjamin Mayhew maintains Andersons (NASDAQ:ANDE) with a Outperform and raises the price target from $75 to $90.
SeekingAlpha · Aug 5, 2026
The Andersons' recent catalystsâfull ethanol ownership, 45Z tax credits, and operational efficienciesâare fully priced in. Read why ANDE stock is a Sell.
SeekingAlpha · Aug 4, 2026
The Andersons, Inc. (ANDE) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsMichael Hoelter - VP, Corporate Controller & Investor...
SeekingAlpha · Aug 4, 2026
2026-08-04. The following slide deck was published by The Andersons, Inc.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ANDE.